As every year, at the end of the Cosmetic Valley Perfumes & Cosmetics Congress held on December 1st and 2nd, 2021, the entire FEBEA team answered questions prepared by the congressmen during the two days of conferences. A session punctuated by numerous questions about ingredients under stress, nanomaterials, CMRs or preservatives, and by labelling issues, especially allergens.
They answered questions from delegates
• Françoise Audebert, Scientific and Regulatory Advisor
• Catherine Bramaud, Scientific and Regulatory Advisor
• Laure Menanteau, Scientific and Regulatory Advisor
• Carlota Vicente, Environmental Affairs Officer
• Xavier Gueant, Director of Legal Affairs
• Valérie Colin, Director of Scientific and Regulatory Affairs
Ingredients
Question
In the context of the development of a new active ingredient with its supplier, the INCI name of the active ingredient is not indicated in the inventories of the cosmetic sector (glossary, Cosing and PCPC). According to the Cosmetics Regulation, the glossary should be applied. However, if the ingredient does not correspond to any of the names listed in the glossary, Article 19-6 of the Regulation should be applied and a generally accepted nomenclature used. What is generally accepted nomenclature?
Catherine Bramaud’s answer
If it is a new cosmetic active, it is preferable to apply for the INCI name to the PCPC, this is the classic approach to adopt. An application file must be drawn up and when the INCI name is allocated, the new INCIs are regularly transferred to the European Commission, which then integrates them into the CosIng. This is the most permanent solution for an industrialist to …
